Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Assets (2019 - 2025)

Serina Therapeutics' Return on Assets history spans 6 years, with the latest figure at 0.06% for Q2 2024.

  • For Q2 2024, Return on Assets rose 54.0% year-over-year to 0.06%; the TTM value through Jun 2024 reached 0.06%, up 54.0%, while the annual FY2024 figure was 2.24%, 164.0% down from the prior year.
  • Return on Assets for Q2 2024 was 0.06% at Serina Therapeutics, down from 0.25% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.38% in Q4 2023 and bottomed at 4.21% in Q4 2022.
  • The 5-year median for Return on Assets is 0.56% (2023), against an average of 0.94%.
  • The largest annual shift saw Return on Assets plummeted -417bps in 2022 before it soared 458bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.18% in 2020, then surged by 79bps to 0.04% in 2021, then crashed by -11302bps to 4.21% in 2022, then soared by 109bps to 0.38% in 2023, then crashed by -115bps to 0.06% in 2024.
  • Per Business Quant, the three most recent readings for SER's Return on Assets are 0.06% (Q2 2024), 0.25% (Q1 2024), and 0.38% (Q4 2023).